BGI Genomics Statistics

Total Valuation

BGI Genomics has a market cap or net worth of CNY 22.06 billion. The enterprise value is 18.81 billion.

Market Cap	22.06B
Enterprise Value	18.81B

Important Dates

The last earnings date was Saturday, April 26, 2025.

Earnings Date	Apr 26, 2025
Ex-Dividend Date	Jul 4, 2024

Share Statistics

BGI Genomics has 381.35 million shares outstanding. The number of shares has increased by 2.89% in one year.

Current Share Class	381.35M
Shares Outstanding	381.35M
Shares Change (YoY)	+2.89%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	10.85%
Float	197.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	800.62
PS Ratio	5.94
PB Ratio	2.39
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.44
EV / Sales	5.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.05

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.10.

Current Ratio	2.85
Quick Ratio	2.52
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-1.14
Interest Coverage	-22.97

Financial Efficiency

Return on equity (ROE) is -10.16% and return on invested capital (ROIC) is -5.20%.

Return on Equity (ROE)	-10.16%
Return on Assets (ROA)	-4.10%
Return on Invested Capital (ROIC)	-5.20%
Return on Capital Employed (ROCE)	-8.38%
Revenue Per Employee	1.00M
Profits Per Employee	-261,423
Employee Count	3,702
Asset Turnover	0.29
Inventory Turnover	3.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.84% in the last 52 weeks. The beta is 0.86, so BGI Genomics's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+19.84%
50-Day Moving Average	53.75
200-Day Moving Average	45.49
Relative Strength Index (RSI)	54.78
Average Volume (20 Days)	4,176,334

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BGI Genomics had revenue of CNY 3.72 billion and -967.79 million in losses. Loss per share was -2.34.

Revenue	3.72B
Gross Profit	1.39B
Operating Income	-853.62M
Pretax Income	-971.47M
Net Income	-967.79M
EBITDA	-426.60M
EBIT	-853.62M
Loss Per Share	-2.34

Full Income Statement

Balance Sheet

The company has 4.31 billion in cash and 928.70 million in debt, giving a net cash position of 3.38 billion or 8.88 per share.

Cash & Cash Equivalents	4.31B
Total Debt	928.70M
Net Cash	3.38B
Net Cash Per Share	8.88
Equity (Book Value)	9.24B
Book Value Per Share	22.07
Working Capital	4.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -225.43 million and capital expenditures -590.93 million, giving a free cash flow of -816.37 million.

Operating Cash Flow	-225.43M
Capital Expenditures	-590.93M
Free Cash Flow	-816.37M
FCF Per Share	-2.14

Full Cash Flow Statement

Margins

Gross margin is 37.43%, with operating and profit margins of -22.96% and -26.03%.

Gross Margin	37.43%
Operating Margin	-22.96%
Pretax Margin	-26.13%
Profit Margin	-26.03%
EBITDA Margin	-11.48%
EBIT Margin	-22.96%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.20%.

Dividend Per Share	0.10
Dividend Yield	0.20%
Dividend Growth (YoY)	-90.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.89%
Shareholder Yield	-2.69%
Earnings Yield	-4.39%
FCF Yield	-3.70%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BGI Genomics has an Altman Z-Score of 3.87.

Altman Z-Score	3.87
Piotroski F-Score	n/a